HuagongsheHuagongshe Chemistry Print Report · For research reference only
5-amino-1-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)imidazole-4-carboxylic acid → HCID 178516781, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 5-amino-1-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)imidazole-4-carboxylic acid | HCID 11811108 | — |
| Reactant | HCID 178521061 | HCID 178521061 | — |
| Product | HCID 178516781 | HCID 178516781 | — |
Reaction Steps
As another method for the synthesis of coformycin, there is also a known process of producing coformycin in which 5-amino-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)imidazole-4-carboxylic acid is used as the starting material, and is processed by multi-stage reactions to form an intermediate, 3-(β-D-ribofuranosyl)-6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one, followed by reducing the latter intermediate [see, H. J. Thomas et al.; "Nucleosides & Nucleotides" 5, No. 4, pp.431-439 (1986)]
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US05773607 |
| Source dataset | uspto-grants-1998_06 |
| ORD ID | ord-02bc44303fd84cc39c5d7001a8846c81 |
| Source note | uspto-grants-1998_06 |